Find a company
Astrimmune is developing a diagnostic test for pancreatic and other gastrointestinal cancers based on detection and profiling of shed tumour cells in the blood. Requiring only 6ml of blood, the test provides unique insight into surface markers and gene expression of pancreatic cancer cells; isolating these cells from blood allows detection before metastasis can occur. Survival rates of pancreatic cancer could be improved dramatically if early detection were possible.
Project | Implementation and Validation of a novel test for pancreatic and other gastrointestinal cancers based on shed tumour cells in the blood |
---|---|
Description |
Astrimmune is developing a diagnostic test for pancreatic and other gastrointestinal cancers based on detection and profiling of shed tumour cells in the blood. Requiring only 6ml of blood, the test provides unique insight into surface markers and gene expression of pancreatic cancer cells; isolating these cells from blood allows detection before metastasis can occur. Survival rates of pancreatic cancer could be improved dramatically if early detection were possible. |
Funding | £ 912,650 |
Competition | Competition 5 - Improving Diagnosis and Treatment Management of Cancer |
Competition Date | September 2013 |
Categories | Cancer , Oral & gastrointestinal |
Health Innovation Network Partner | Health Innovation East Midlands |
Website | https://uk.linkedin.com/company/astrimmune |
Astrimmune is developing a diagnostic test for pancreatic and other gastrointestinal cancers based on detection and profiling of shed tumour cells in the blood. Requiring only 6ml of blood, the test provides unique insight into surface markers and gene expression of pancreatic cancer cells; isolating these cells from blood allows detection before metastasis can occur. Survival rates of pancreatic cancer could be improved dramatically if early detection were possible.
Project | High throughput fluid-flow cell-Imaging for cancer monitoring |
---|---|
Funding | £ 83,333 |
Competition | Competition 8 - Medical Imaging: viewing, managing and analysing the wealth of data |
Competition Date | October 2014 |
Categories | Cancer |
Health Innovation Network Partner | Health Innovation East Midlands |
Website | https://uk.linkedin.com/company/astrimmune |